SeladelparUDCAfenofibrateelafibranorObeticholic acidursodeoxycholic acid (UDCA)OCASEL-2LOCA-switchPrimary biliary cholangitis (PBC)
… was recently withdrawn from the US creating a therapeutic gap. Seladelpar (SEL), approved in 2024 in the US for patients with PBC and an …